查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1862242

病毒清除服务：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Viral Clearance Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球病毒清除服务市场预计在 2024 年达到 5.72 亿美元，预计到 2031 年将达到 16.67 亿美元，2025 年至 2031 年的复合年增长率为 16.5%。

病毒去除服务是指去除或灭活病毒。病毒去除检测是确保生物製药达到可接受的病毒安全性水准的关键环节。这些检测的目的是证明生产和纯化製程能够灭活和/或去除已知或可能污染原料的病毒，以及其他种类的病毒。病毒去除检测是细胞库、原料和生物反应器收穫物直接检测的补充，后者可能无法检测到所有可能污染产品的病毒。

病毒去除服务市场的主要驱动力是全球生物製药行业的快速成长以及日益严格的产品安全性和合规性监管要求。随着单株抗体、重组蛋白、细胞疗法和基因疗法等生物製药的广泛应用，生产过程中病毒污染的风险已成为监管机构关注的焦点，从而推动了对可靠的病毒去除检验服务的需求。寻求临床试验核准和产品商业化的生物製药公司必须提交全面的病毒去除数据，以满足FDA和EMA等监管机构的严格标准，这使得这些服务在产品开发平臺中至关重要。此外，CDMO（合约开发和生产组织）和CRO（受託研究机构）的兴起加速了病毒去除检测的外包，使企业能够提高开发效率并确保合规性。随着全球生物製药供应链的日益一体化以及技术进步不断提高病毒检测和去除方法的灵敏度和可靠性，病毒去除服务市场预计将保持强劲且可持续的成长。

北美是病毒清除服务的最大市场，约占总市场份额的51%，其次是欧洲，约占总市场份额的23%。主要生产商包括Charles River、BioReliance（默克）、Eurofins Scientific、Sartorius、Covance、ViruSure、Texcell、Bioscience Labs、Vironova Biosafety、Merieux NutriSciences、药明康德、Syngene和Labor Dr. Merk。前三大公司约占39%的市占率。

本报告旨在按地区/国家、应用程式和最终用户对全球病毒清除服务市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告以2024年为基准年，按销售收入提供病毒清除服务市场规模、估算和预测，并包含2020年至2031年期间的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定业务/成长策略，评估市场竞争格局，分析自身在当前市场中的地位，并就病毒清除服务做出明智的商业决策。

市场区隔

公司

  • Charles River
  • Sigma-Aldrich（Merck）
  • Eurofins Scientific
  • Sartorius
  • Labcorp
  • ViruSure
  • Texcell
  • Bioscience Labs
  • QuTEM
  • Merieux NutriSciences
  • WuXi AppTec
  • Syngene
  • Boehringer Ingelheim
  • Sino Biological
  • Creative Biogene

应用领域

  • 製药业
  • 生物製药
  • 用于医疗设备

最终使用者群体

  • 研究所
  • 製药业
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Viral Clearance Service was estimated to be worth US$ 572 million in 2024 and is forecast to a readjusted size of US$ 1667 million by 2031 with a CAGR of 16.5% during the forecast period 2025-2031.

Viral clearance services refer to viral removal or viral inactivation service. Viral clearance studies are a critical element toward ensuring that an acceptable level of viral safety has been achieved for biological products. The goal of these studies is to demonstrate that the manufacturing purification process has the ability to inactivate and/or remove viruses that are known to contaminate or which may possibly contaminate the starting materials, as well as additional viruses that are models for a broad variety of viruses. Viral clearance studies provide a complementary strategy to direct testing of cell banks, raw materials and bioreactor harvests, which may not detect all viruses that could potentially contaminate the product.

The viral clearance service market is primarily driven by the rapid growth of the global biopharmaceutical industry and increasingly stringent regulatory requirements for product safety and compliance. With the widespread adoption of biologics such as monoclonal antibodies, recombinant proteins, cell therapies, and gene therapies, the risk of viral contamination during production has become a critical concern for regulatory agencies, fueling demand for robust viral clearance validation services. Biopharmaceutical companies seeking clinical trial approval or product commercialization are required to submit comprehensive viral clearance data to meet the stringent standards of regulatory bodies like the FDA, EMA, and others, making these services essential to product development pipelines. Additionally, the rise of CDMOs (Contract Development and Manufacturing Organizations) and CROs (Contract Research Organizations) has accelerated the outsourcing of viral clearance testing, allowing companies to improve development efficiency and ensure regulatory compliance. As the global biopharma supply chain becomes more integrated and technological advancements continue to enhance the sensitivity and reliability of viral detection and removal methods, the viral clearance service market is expected to maintain strong and sustained growth.

North America is the largest Viral Clearance Service market with about 51% market share. Europe is follower, accounting for about 23% market share.The key manufacturers are Charles River, BioReliance (Merck), Eurofins Scientific, Sartorius, Covance, ViruSure, Texcell, Bioscience Labs, Vironova Biosafety, Merieux NutriSciences, WuXi AppTec, Syngene, Labor Dr. Merk etc. Top 3 companies occupied about 39% market share.

This report aims to provide a comprehensive presentation of the global market for Viral Clearance Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Viral Clearance Service by region & country, by Application, and by End User.

The Viral Clearance Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Clearance Service.

Market Segmentation

By Company

  • Charles River
  • Sigma-Aldrich (Merck)
  • Eurofins Scientific
  • Sartorius
  • Labcorp
  • ViruSure
  • Texcell
  • Bioscience Labs
  • QuTEM
  • Merieux NutriSciences
  • WuXi AppTec
  • Syngene
  • Boehringer Ingelheim
  • Sino Biological
  • Creative Biogene

Segment by Application

  • For Pharmaceuticals
  • For Biopharmaceuticals
  • For Medical Devices

Segment by End User

  • Research Institution
  • Pharmaceutical Industry
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Viral Clearance Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Viral Clearance Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Viral Clearance Service in country level. It provides sigmate data by Application, and by End User for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Viral Clearance Service Product Introduction
  • 1.2 Global Viral Clearance Service Market Size Forecast (2020-2031)
  • 1.3 Viral Clearance Service Market Trends & Drivers
    • 1.3.1 Viral Clearance Service Industry Trends
    • 1.3.2 Viral Clearance Service Market Drivers & Opportunity
    • 1.3.3 Viral Clearance Service Market Challenges
    • 1.3.4 Viral Clearance Service Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Viral Clearance Service Players Revenue Ranking (2024)
  • 2.2 Global Viral Clearance Service Revenue by Company (2020-2025)
  • 2.3 Key Companies Viral Clearance Service Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Viral Clearance Service Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Viral Clearance Service
  • 2.6 Viral Clearance Service Market Competitive Analysis
    • 2.6.1 Viral Clearance Service Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Viral Clearance Service Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Clearance Service as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Application

  • 3.1 Introduction by Application
    • 3.1.1 For Pharmaceuticals
    • 3.1.2 For Biopharmaceuticals
    • 3.1.3 For Medical Devices
  • 3.2 Global Viral Clearance Service Sales Value by Application
    • 3.2.1 Global Viral Clearance Service Sales Value by Application (2020 VS 2024 VS 2031)
    • 3.2.2 Global Viral Clearance Service Sales Value, by Application (2020-2031)
    • 3.2.3 Global Viral Clearance Service Sales Value, by Application (%) (2020-2031)

4 Segmentation by End User

  • 4.1 Introduction by End User
    • 4.1.1 Research Institution
    • 4.1.2 Pharmaceutical Industry
    • 4.1.3 Others
  • 4.2 Global Viral Clearance Service Sales Value by End User
    • 4.2.1 Global Viral Clearance Service Sales Value by End User (2020 VS 2024 VS 2031)
    • 4.2.2 Global Viral Clearance Service Sales Value, by End User (2020-2031)
    • 4.2.3 Global Viral Clearance Service Sales Value, by End User (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Viral Clearance Service Sales Value by Region
    • 5.1.1 Global Viral Clearance Service Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Viral Clearance Service Sales Value by Region (2020-2025)
    • 5.1.3 Global Viral Clearance Service Sales Value by Region (2026-2031)
    • 5.1.4 Global Viral Clearance Service Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Viral Clearance Service Sales Value, 2020-2031
    • 5.2.2 North America Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Viral Clearance Service Sales Value, 2020-2031
    • 5.3.2 Europe Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Viral Clearance Service Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Viral Clearance Service Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Viral Clearance Service Sales Value, 2020-2031
    • 5.5.2 South America Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Viral Clearance Service Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Viral Clearance Service Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Viral Clearance Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Viral Clearance Service Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Viral Clearance Service Sales Value, 2020-2031
    • 6.3.2 United States Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
    • 6.3.3 United States Viral Clearance Service Sales Value by End User, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Viral Clearance Service Sales Value, 2020-2031
    • 6.4.2 Europe Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
    • 6.4.3 Europe Viral Clearance Service Sales Value by End User, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Viral Clearance Service Sales Value, 2020-2031
    • 6.5.2 China Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
    • 6.5.3 China Viral Clearance Service Sales Value by End User, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Viral Clearance Service Sales Value, 2020-2031
    • 6.6.2 Japan Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
    • 6.6.3 Japan Viral Clearance Service Sales Value by End User, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Viral Clearance Service Sales Value, 2020-2031
    • 6.7.2 South Korea Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
    • 6.7.3 South Korea Viral Clearance Service Sales Value by End User, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Viral Clearance Service Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Viral Clearance Service Sales Value by End User, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Viral Clearance Service Sales Value, 2020-2031
    • 6.9.2 India Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
    • 6.9.3 India Viral Clearance Service Sales Value by End User, 2024 VS 2031

7 Company Profiles

  • 7.1 Charles River
    • 7.1.1 Charles River Profile
    • 7.1.2 Charles River Main Business
    • 7.1.3 Charles River Viral Clearance Service Products, Services and Solutions
    • 7.1.4 Charles River Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Charles River Recent Developments
  • 7.2 Sigma-Aldrich (Merck)
    • 7.2.1 Sigma-Aldrich (Merck) Profile
    • 7.2.2 Sigma-Aldrich (Merck) Main Business
    • 7.2.3 Sigma-Aldrich (Merck) Viral Clearance Service Products, Services and Solutions
    • 7.2.4 Sigma-Aldrich (Merck) Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Sigma-Aldrich (Merck) Recent Developments
  • 7.3 Eurofins Scientific
    • 7.3.1 Eurofins Scientific Profile
    • 7.3.2 Eurofins Scientific Main Business
    • 7.3.3 Eurofins Scientific Viral Clearance Service Products, Services and Solutions
    • 7.3.4 Eurofins Scientific Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Eurofins Scientific Recent Developments
  • 7.4 Sartorius
    • 7.4.1 Sartorius Profile
    • 7.4.2 Sartorius Main Business
    • 7.4.3 Sartorius Viral Clearance Service Products, Services and Solutions
    • 7.4.4 Sartorius Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Sartorius Recent Developments
  • 7.5 Labcorp
    • 7.5.1 Labcorp Profile
    • 7.5.2 Labcorp Main Business
    • 7.5.3 Labcorp Viral Clearance Service Products, Services and Solutions
    • 7.5.4 Labcorp Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Labcorp Recent Developments
  • 7.6 ViruSure
    • 7.6.1 ViruSure Profile
    • 7.6.2 ViruSure Main Business
    • 7.6.3 ViruSure Viral Clearance Service Products, Services and Solutions
    • 7.6.4 ViruSure Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.6.5 ViruSure Recent Developments
  • 7.7 Texcell
    • 7.7.1 Texcell Profile
    • 7.7.2 Texcell Main Business
    • 7.7.3 Texcell Viral Clearance Service Products, Services and Solutions
    • 7.7.4 Texcell Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Texcell Recent Developments
  • 7.8 Bioscience Labs
    • 7.8.1 Bioscience Labs Profile
    • 7.8.2 Bioscience Labs Main Business
    • 7.8.3 Bioscience Labs Viral Clearance Service Products, Services and Solutions
    • 7.8.4 Bioscience Labs Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Bioscience Labs Recent Developments
  • 7.9 QuTEM
    • 7.9.1 QuTEM Profile
    • 7.9.2 QuTEM Main Business
    • 7.9.3 QuTEM Viral Clearance Service Products, Services and Solutions
    • 7.9.4 QuTEM Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.9.5 QuTEM Recent Developments
  • 7.10 Merieux NutriSciences
    • 7.10.1 Merieux NutriSciences Profile
    • 7.10.2 Merieux NutriSciences Main Business
    • 7.10.3 Merieux NutriSciences Viral Clearance Service Products, Services and Solutions
    • 7.10.4 Merieux NutriSciences Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Merieux NutriSciences Recent Developments
  • 7.11 WuXi AppTec
    • 7.11.1 WuXi AppTec Profile
    • 7.11.2 WuXi AppTec Main Business
    • 7.11.3 WuXi AppTec Viral Clearance Service Products, Services and Solutions
    • 7.11.4 WuXi AppTec Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.11.5 WuXi AppTec Recent Developments
  • 7.12 Syngene
    • 7.12.1 Syngene Profile
    • 7.12.2 Syngene Main Business
    • 7.12.3 Syngene Viral Clearance Service Products, Services and Solutions
    • 7.12.4 Syngene Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Syngene Recent Developments
  • 7.13 Boehringer Ingelheim
    • 7.13.1 Boehringer Ingelheim Profile
    • 7.13.2 Boehringer Ingelheim Main Business
    • 7.13.3 Boehringer Ingelheim Viral Clearance Service Products, Services and Solutions
    • 7.13.4 Boehringer Ingelheim Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Boehringer Ingelheim Recent Developments
  • 7.14 Sino Biological
    • 7.14.1 Sino Biological Profile
    • 7.14.2 Sino Biological Main Business
    • 7.14.3 Sino Biological Viral Clearance Service Products, Services and Solutions
    • 7.14.4 Sino Biological Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Sino Biological Recent Developments
  • 7.15 Creative Biogene
    • 7.15.1 Creative Biogene Profile
    • 7.15.2 Creative Biogene Main Business
    • 7.15.3 Creative Biogene Viral Clearance Service Products, Services and Solutions
    • 7.15.4 Creative Biogene Viral Clearance Service Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Creative Biogene Recent Developments

8 Industry Chain Analysis

  • 8.1 Viral Clearance Service Industrial Chain
  • 8.2 Viral Clearance Service Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Viral Clearance Service Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Viral Clearance Service Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Viral Clearance Service Market Trends
  • Table 2. Viral Clearance Service Market Drivers & Opportunity
  • Table 3. Viral Clearance Service Market Challenges
  • Table 4. Viral Clearance Service Market Restraints
  • Table 5. Global Viral Clearance Service Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Viral Clearance Service Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Viral Clearance Service Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Viral Clearance Service Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Viral Clearance Service
  • Table 10. Global Viral Clearance Service Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Clearance Service as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Viral Clearance Service Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Viral Clearance Service Sales Value by Application (2020-2025) & (US$ Million)
  • Table 15. Global Viral Clearance Service Sales Value by Application (2026-2031) & (US$ Million)
  • Table 16. Global Viral Clearance Service Sales Market Share in Value by Application (2020-2025)
  • Table 17. Global Viral Clearance Service Sales Market Share in Value by Application (2026-2031)
  • Table 18. Global Viral Clearance Service Sales Value by End User: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Viral Clearance Service Sales Value by End User (2020-2025) & (US$ Million)
  • Table 20. Global Viral Clearance Service Sales Value by End User (2026-2031) & (US$ Million)
  • Table 21. Global Viral Clearance Service Sales Market Share in Value by End User (2020-2025)
  • Table 22. Global Viral Clearance Service Sales Market Share in Value by End User (2026-2031)
  • Table 23. Global Viral Clearance Service Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Viral Clearance Service Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Viral Clearance Service Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Viral Clearance Service Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Viral Clearance Service Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Viral Clearance Service Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Viral Clearance Service Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Viral Clearance Service Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Charles River Basic Information List
  • Table 32. Charles River Description and Business Overview
  • Table 33. Charles River Viral Clearance Service Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Viral Clearance Service Business of Charles River (2020-2025)
  • Table 35. Charles River Recent Developments
  • Table 36. Sigma-Aldrich (Merck) Basic Information List
  • Table 37. Sigma-Aldrich (Merck) Description and Business Overview
  • Table 38. Sigma-Aldrich (Merck) Viral Clearance Service Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Viral Clearance Service Business of Sigma-Aldrich (Merck) (2020-2025)
  • Table 40. Sigma-Aldrich (Merck) Recent Developments
  • Table 41. Eurofins Scientific Basic Information List
  • Table 42. Eurofins Scientific Description and Business Overview
  • Table 43. Eurofins Scientific Viral Clearance Service Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Viral Clearance Service Business of Eurofins Scientific (2020-2025)
  • Table 45. Eurofins Scientific Recent Developments
  • Table 46. Sartorius Basic Information List
  • Table 47. Sartorius Description and Business Overview
  • Table 48. Sartorius Viral Clearance Service Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Viral Clearance Service Business of Sartorius (2020-2025)
  • Table 50. Sartorius Recent Developments
  • Table 51. Labcorp Basic Information List
  • Table 52. Labcorp Description and Business Overview
  • Table 53. Labcorp Viral Clearance Service Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Viral Clearance Service Business of Labcorp (2020-2025)
  • Table 55. Labcorp Recent Developments
  • Table 56. ViruSure Basic Information List
  • Table 57. ViruSure Description and Business Overview
  • Table 58. ViruSure Viral Clearance Service Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Viral Clearance Service Business of ViruSure (2020-2025)
  • Table 60. ViruSure Recent Developments
  • Table 61. Texcell Basic Information List
  • Table 62. Texcell Description and Business Overview
  • Table 63. Texcell Viral Clearance Service Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Viral Clearance Service Business of Texcell (2020-2025)
  • Table 65. Texcell Recent Developments
  • Table 66. Bioscience Labs Basic Information List
  • Table 67. Bioscience Labs Description and Business Overview
  • Table 68. Bioscience Labs Viral Clearance Service Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Viral Clearance Service Business of Bioscience Labs (2020-2025)
  • Table 70. Bioscience Labs Recent Developments
  • Table 71. QuTEM Basic Information List
  • Table 72. QuTEM Description and Business Overview
  • Table 73. QuTEM Viral Clearance Service Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Viral Clearance Service Business of QuTEM (2020-2025)
  • Table 75. QuTEM Recent Developments
  • Table 76. Merieux NutriSciences Basic Information List
  • Table 77. Merieux NutriSciences Description and Business Overview
  • Table 78. Merieux NutriSciences Viral Clearance Service Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Viral Clearance Service Business of Merieux NutriSciences (2020-2025)
  • Table 80. Merieux NutriSciences Recent Developments
  • Table 81. WuXi AppTec Basic Information List
  • Table 82. WuXi AppTec Description and Business Overview
  • Table 83. WuXi AppTec Viral Clearance Service Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Viral Clearance Service Business of WuXi AppTec (2020-2025)
  • Table 85. WuXi AppTec Recent Developments
  • Table 86. Syngene Basic Information List
  • Table 87. Syngene Description and Business Overview
  • Table 88. Syngene Viral Clearance Service Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Viral Clearance Service Business of Syngene (2020-2025)
  • Table 90. Syngene Recent Developments
  • Table 91. Boehringer Ingelheim Basic Information List
  • Table 92. Boehringer Ingelheim Description and Business Overview
  • Table 93. Boehringer Ingelheim Viral Clearance Service Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Viral Clearance Service Business of Boehringer Ingelheim (2020-2025)
  • Table 95. Boehringer Ingelheim Recent Developments
  • Table 96. Sino Biological Basic Information List
  • Table 97. Sino Biological Description and Business Overview
  • Table 98. Sino Biological Viral Clearance Service Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Viral Clearance Service Business of Sino Biological (2020-2025)
  • Table 100. Sino Biological Recent Developments
  • Table 101. Creative Biogene Basic Information List
  • Table 102. Creative Biogene Description and Business Overview
  • Table 103. Creative Biogene Viral Clearance Service Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Viral Clearance Service Business of Creative Biogene (2020-2025)
  • Table 105. Creative Biogene Recent Developments
  • Table 106. Key Raw Materials Lists
  • Table 107. Raw Materials Key Suppliers Lists
  • Table 108. Viral Clearance Service Downstream Customers
  • Table 109. Viral Clearance Service Distributors List
  • Table 110. Research Programs/Design for This Report
  • Table 111. Key Data Information from Secondary Sources
  • Table 112. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Viral Clearance Service Product Picture
  • Figure 2. Global Viral Clearance Service Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Viral Clearance Service Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Viral Clearance Service Report Years Considered
  • Figure 5. Global Viral Clearance Service Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Viral Clearance Service Revenue in 2024
  • Figure 7. Viral Clearance Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. For Pharmaceuticals Picture
  • Figure 9. For Biopharmaceuticals Picture
  • Figure 10. For Medical Devices Picture
  • Figure 11. Global Viral Clearance Service Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Viral Clearance Service Sales Value Market Share by Application, 2024 & 2031
  • Figure 13. Product Picture of Research Institution
  • Figure 14. Product Picture of Pharmaceutical Industry
  • Figure 15. Product Picture of Others
  • Figure 16. Global Viral Clearance Service Sales Value by End User (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Viral Clearance Service Sales Value Market Share by End User, 2024 & 2031
  • Figure 18. North America Viral Clearance Service Sales Value (2020-2031) & (US$ Million)
  • Figure 19. North America Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Europe Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Europe Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Asia Pacific Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Asia Pacific Viral Clearance Service Sales Value by Region (%), 2024 VS 2031
  • Figure 24. South America Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. South America Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Middle East & Africa Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. Middle East & Africa Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Key Countries/Regions Viral Clearance Service Sales Value (%), (2020-2031)
  • Figure 29. United States Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. United States Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • Figure 31. United States Viral Clearance Service Sales Value by End User (%), 2024 VS 2031
  • Figure 32. Europe Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Europe Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • Figure 34. Europe Viral Clearance Service Sales Value by End User (%), 2024 VS 2031
  • Figure 35. China Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. China Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • Figure 37. China Viral Clearance Service Sales Value by End User (%), 2024 VS 2031
  • Figure 38. Japan Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Japan Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Japan Viral Clearance Service Sales Value by End User (%), 2024 VS 2031
  • Figure 41. South Korea Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. South Korea Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • Figure 43. South Korea Viral Clearance Service Sales Value by End User (%), 2024 VS 2031
  • Figure 44. Southeast Asia Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Southeast Asia Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Southeast Asia Viral Clearance Service Sales Value by End User (%), 2024 VS 2031
  • Figure 47. India Viral Clearance Service Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. India Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • Figure 49. India Viral Clearance Service Sales Value by End User (%), 2024 VS 2031
  • Figure 50. Viral Clearance Service Industrial Chain
  • Figure 51. Viral Clearance Service Manufacturing Cost Structure
  • Figure 52. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 53. Bottom-up and Top-down Approaches for This Report
  • Figure 54. Data Triangulation
  • Figure 55. Key Executives Interviewed